Thursday, January 3, 2008

(NASDAQ: VSEA), (NYSE: KWK), (AMEX: SRG),(NASDAQ: ELOS).

RealPennies.com: Turning Pennies into dollars: (NASDAQ: VSEA), (NYSE: KWK), (AMEX: SRG),(NASDAQ: ELOS).

Are you a public company looking for exposure?
Contact RealPennies.com - 1.800.940.6559

For more info: http://vsea.realpennies.com

Varian Semiconductor Equipment Associates, Inc. (NASDAQ: VSEA) announced yesterday that the company will deliver a presentation at the 10th Annual Needham Growth Stock Conference in New York, NY on Tuesday, January 8, 2008 at 3:00 pm eastern time.

Varian Semiconductor Equipment Associates, Inc. is the leading producer of ion implantation equipment used in the manufacture of semiconductors. The company is headquartered in Gloucester, Massachusetts, and operates worldwide. Varian Semiconductor maintains a website at www.vsea.com. The information contained in the company's website is not incorporated by reference into this release, and the website address is included in this release as an inactive textual reference only.

For more info: http://kwk.realpennies.com

Quicksilver Resources Inc. (NYSE: KWK) announced yesterday that, due to the satisfaction of the market price condition to conversion, the company's 1.875% Convertible Subordinated Debentures due 2024 (the "Debentures") are convertible during the fiscal quarter ending March 31, 2008. Pursuant to the terms of the indenture under which the Debentures were issued, the Debentures are currently convertible at a rate of 32.7209 shares of common stock of Quicksilver Resources per $1,000 principal amount of the Debentures (such conversion rate having been adjusted to account for a 3-for-2 stock split effected in the form of a stock dividend on June 30, 2005). These shares are included in the company's fully diluted earnings per share calculation.

Fort Worth, Texas-based Quicksilver Resources is a natural gas and crude oil exploration and production company engaged in the development and acquisition of long-lived, unconventional natural gas reserves, including coal bed methane, shale gas, and tight sands gas in North America. The company has U.S. offices in Fort Worth, Texas; Granbury, Texas and Cut Bank, Montana. Quicksilver's Canadian subsidiary, Quicksilver Resources Canada Inc., is headquartered in Calgary, Alberta. For more information about Quicksilver Resources, visit www.qrinc.com.

For more info: http://srg.realpennies.com

Seanergy Maritime Corp. (AMEX: SRG) (AMEX: SRG.U) (AMEX: SRG.W) announced yesterday its first quarterly distribution to public shareholders for the period from the consummation of the Company's Initial Public Offering on September 28, 2007, through and including December 31, 2007.

The Company announced that it will pay a distribution, consisting of the interest earned in the Trust Account, subject to certain permitted adjustments, of $1,630,791 in total or $0.0706 per share for such period. This distribution will be paid on January 15, 2008 to public shareholders of record on January 9, 2008.

Seanergy Maritime Corp. is a Business Combination Company, or BCC. A BCC is a blank check company formed for the purpose of acquiring, through a merger, capital stock exchange, asset acquisition or other similar business combination, an unidentified operating business. The Company intends to focus on identifying one or more businesses or assets in the maritime shipping industry, but will not be limited to pursuing acquisition opportunities only within that industry.

For more info: http://elos.realpennies.com

Syneron Medical Ltd. (NASDAQ: ELOS), an innovator in the development, marketing and sales of elos combined-energy medical aesthetic devices, announced yesterday that the transition in the management of the R&D department from CTO, Dr. Michael Kreindel, to Dr. Boris Vaynberg who was appointed Vice President for R&D in July 2007. Dr. Kreindel will also resign his Board position.

Dr. Vaynberg is the co-founder of Light Instruments, which developed Syneron's LightTouch dental laser. From 2005 to 2007, Dr. Vaynberg served as CEO of Light Instruments, which subsequently was acquired by Syneron and became its Dental Division. Prior to founding and managing Light Instruments, Dr. Vaynberg was Head of the physics and laser group in Lumenis / ESC Sharplan. Dr. Vaynberg holds a Ph.D. in Laser and Electro-Optics from Bar Ilan University which he received in 1996 and an M.Sc. in Opto-Electronics from Chernovtsy State University in Ukraine where he developed semiconductor blue light sources. Dr. Vaynberg has more than 10 registered patents and applications.

Commenting on Dr. Kreindel's departure and on the appointment of Dr. Vaynberg, Syneron's Chairman of the Board Shimon Eckhouse, said, "Michael and I worked together on the scientific and technological breakthroughs in non-invasive aesthetic medicine that culminated in Syneron's ELOS technology. I want to thank Michael for his very significant contribution to Syneron and to the advancement of energy-based non-invasive aesthetic medicine."

"I am very pleased to see Boris leading our technology development efforts at Syneron," Dr. Eckhouse continued. "I have known and worked closely with Boris for more than 10 years and have no doubt that he will play a very significant role in enhancing our leadership position in non-invasive aesthetic medicine."

Syneron Medical Ltd. (NASDAQ: ELOS) manufactures and distributes medical aesthetic devices that are powered by the proprietary, patented elos combined-energy technology of Bi-Polar Radio Frequency and Light. The Company's innovative elos technology provides the foundation for highly effective, safe and cost-effective systems that enable physicians to provide advanced solutions for a broad range of medical-aesthetic applications including hair removal, wrinkle reduction, rejuvenating the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, and the treatment of acne, leg veins and cellulite. Founded in 2000, the corporate, R&D, and manufacturing headquarters for Syneron Medical Ltd. is located in Israel. Syneron has offices and distributors throughout the world, including North American Headquarters in Canada, North American Logistics Center in Irvine, California, European Headquarters in Germany, and Asia-Pacific Headquarters in Hong Kong, which provide sales, service and support. Additional information can be found at www.syneron.com.

Syneron, the Syneron logo, LightTouch and elos are trademarks of Syneron Medical Ltd. and may be registered in certain jurisdictions. Elos (Electro-Optical Synergy) is a proprietary technology of Syneron Medical. All other names are the property of their respective owners.

Read our full disclaimer at: http://www.realpennies.com/start.html

Investors are advised that this analysis is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy. This report does not have regard to the specific investment objectives, financial situation and the particular needs of any specific person who may receive this information. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Past performance is no guarantee of future results. Please consult a broker before purchasing or selling any securities mentioned on RealPennies. For more movers: http://www.realpennies.com/wrapup.html

Any opinions expressed herein are statements of our judgment as of the date of publication and are subject to change without notice.
Sitemap: http://www.realpennies.com/sitemap.html

RealPennies .

Telephone: 1-800-940-6559

Matt /at/ realpennies.com

No comments: